Annals of Behavioral Medicine

, Volume 32, Issue 1, pp 10–20 | Cite as

Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis

Article

Abstract

Background: Quitting smoking improves prognosis after a cardiac event. Therefore smoking cessation is highly recommended for patients with coronary heart disease (CHD), but many patients continue to smoke, and improved cessation aids are urgently required.Purpose: The objective was to conduct a systematic review of the efficacy of psychosocial interventions to quit smoking in patients with CHD.Methods: Seven electronic databases were searched from the start of the database to August 2003. Search terms were coronary or cardio or heart or cvd or chd and smok* and cessation or absti*. Results were supplemented by cross-checking references. More than 2,000 papers were screened in a first step. Eligibility of studies was assessed (by reviewer Jürgen Barth) and reasons for exclusion were coded. Abstinence rates were computed both according to an intention to treat analysis, and based on follow-up results only.Results:We found 19 randomized controlled trials, comparing a specific psychosocial intervention with “usual care,” with a minimum of 6-month follow-up. Interventions consist of behavioral therapeutic approaches, telephone support, and self-help material. The trials mostly included older male patients with CHD, predominantly myocardial infarction. Overall results found a positive effect of interventions on abstinence after 6 to 12 months (OR = 1.66, 95% CI = 1.24–2.21), but substantial heterogeneity between trials. Clustering the trials by type of intervention reduced heterogeneity, although many trials used more than one type of intervention. Trials involving behavioral therapies or telephone contact were little different from self-help techniques (OR = 1.65, 95% CI = 1.28–2.13 for behavioral therapies; OR = 1.58, 95% CI = 1.26–1.98 for telephone sup support; OR = 1.47, 95% CI = 1.10–1.97 for self-help). Treatment intensity was associated with study outcome. More intense interventions showed increased quit rates (OR = 1.95, 95% CI = 1.61–2.35) whereas interventions of low intensity did not appear effective (OR = 0.92, 95% CI = 0.70–1.22). Studies with validated assessment of smoking status at follow-up had lower efficacy than nonvalidated trials.Conclusions: Smoking cessation interventions are effective in promoting abstinence up to 1 year, provided they are of sufficient intensity with a minimum length of 1 month. Further studies should compare different psychosocial intervention strategies, or the combination of a psychosocial intervention strategy with nicotine replacement therapy or bupropion compared with nicotine replacement or bupropion alone.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Keil U, Liese AD, Hense HW, et al.: Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany.European Heart Journal. 1998,19:1197–1207.PubMedCrossRefGoogle Scholar
  2. (2).
    Willett WC, Green A, Stampfer MJ, et al.: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.The New England Journal of Medicine. 1987,317:1303–1309.PubMedCrossRefGoogle Scholar
  3. (3).
    Tunstall-Pedoe H, Woodward M, Tavendale R, A Brook R, McCluskey MK: Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: Cohort study.British Medical Journal. 1997,315:722–729.PubMedGoogle Scholar
  4. (4).
    Aberg A, Bergstrand R, Johansson S, et al.: Cessation of smoking after myocardial infarction: Effects on mortality after 10 years.British Heart Journal. 1983,49:416–422.PubMedCrossRefGoogle Scholar
  5. (5).
    Critchley JA, Capewell S: Mortality risk reduction associated with coronary heart disease: Asystematic review.Journal of the American Medical Association. 2003,290:86–97.PubMedCrossRefGoogle Scholar
  6. (6).
    Wilson K, Gibson N, Willan A, Cook D: Effect of smoking cessation on mortality after myocardial infarction.Archives of Internal Medicine. 2000,160:939–944.PubMedCrossRefGoogle Scholar
  7. (7).
    Barth J, Bengel J: Smoking cessation in patients with coronary heart disease: Risk reduction and an evaluation of the efficacy of interventions. In Jordan J, Bardé B, Zeiher A (eds),Evidence Based Psychocardiology. Washington, DC: American Psychological Association, 2006.Google Scholar
  8. (8).
    Silagy C, Stead L:Physician Advice for Smoking Cessation. Retrieved March 3, 2004 from the Cochrane Library.Google Scholar
  9. (9).
    Stead L, Lancaster T:Group Behaviour Therapy Programmes for Smoking Cessation.Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.Google Scholar
  10. (10).
    Lancaster T, Stead L:Individual Behavioural Counselling for Smoking Cessation. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.Google Scholar
  11. (11).
    Stead L, Lancaster T, Perera R:Telephone Counselling for Smoking Cessation. Retrieved March 3, 2003 from Cochrane Database of Systematic Reviews.Google Scholar
  12. (12).
    Lancaster T, Stead L:Self-Help Interventions for Smoking Cessation. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.Google Scholar
  13. (13).
    Rigotti NA, Munafo MR, Murphy MFG, Stead L:Interventions for smoking cessation in hospitalised patients. Retrieved March 3, 2004 from Cochrane Database of Systematic Reviews.Google Scholar
  14. (14).
    Rice VH, Stead L:Nursing Interventions for Smoking Cessation. Retrieved March 3, 2004 from the Cochrane Library.Google Scholar
  15. (15).
    van der Meer RM, Wagena EJ, Ostelo RWJG, Jacobs JE, von Schayck CP:Smoking Cessation for Chronic Obstructive 19 Pulmonary Disease.Retrieved March 3, 2004 from the Cochrane Library.Google Scholar
  16. (16).
    Wiggers LCW, Smets EMA, DeHaes JCJM, Peters RJG, Legemate DA: Smoking cessation interventions in cardiovascular patients.European Journal of Endovascular Surgery. 2003,26:467–475.CrossRefGoogle Scholar
  17. (17).
    De Backer G, Ambrosioni E, Borch-Johnson K, et al.: European guidelines on cardiovascular disease prevention in clinical practice.European Heart Journal. 2003,24:1601–1610.PubMedCrossRefGoogle Scholar
  18. (18).
    Ockene IS, Miller NH: Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association.Circulation. 1997,96:3243–3247.PubMedGoogle Scholar
  19. (19).
    American Heart Association:ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.Retrieved May 27, 2004 from http://www.americanheart.org/downloadable/heart/ 1016214837537UANSTEMI2002Web.pdfGoogle Scholar
  20. (20).
    Davidson KW, Trudeau KJ, Ockene JK, Orleans CT, Kaplan RM: A primer on current evidence-based review systems and their implications for behavioral medicine.Annals of Behavioral Medicine. 2004,28:226–238.PubMedCrossRefGoogle Scholar
  21. (21).
    Bolman C, de Vries H, van Breukelen G: Evaluation of a nurse-managed minimal-contact smoking cessation intervention for cardiac inpatients.Health Education Research. 2002,17:99–116.PubMedCrossRefGoogle Scholar
  22. (22).
    Hedbäck B, Perk J: 5-year results of a comprehensive rehabilitation programm after myocardial infarction.European Heart Journal. 1987,8:234–242.PubMedGoogle Scholar
  23. (23).
    Jolly K, Bradley F, Sharp S, et al.: Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina. Final results of the Southampton heart integrated care project (SHIP).British Medical Journal. 1999,318:706–711.PubMedGoogle Scholar
  24. (24).
    Barber K, Stommel M, Kroll J, Holmes-Rovner M: Cardiac rehabilitation for community-based patients with myocardial -infarction: Factors predicting discharge recommendation and participation.Journal of Clinical Epidemiology. 2001,54:1025–1030.PubMedCrossRefGoogle Scholar
  25. (25).
    de Valle MN, Norman P: Causal attributions, health locus of control beliefs and lifestyle changes among pre-operative coronary patients.Psychology and Health. 1992,7:201–211.CrossRefGoogle Scholar
  26. (26).
    Engblom E, Rönnemaa T, Hömölöinen H, et al.: Coronary heart disease risk factors before and after bypass surgery: Results of a controlled trial on multifactorial rehabilitation.European Heart Journal. 1992,13:232–237.PubMedGoogle Scholar
  27. (27).
    Baughman Kl, Hutter AMJ, DeSanctis RW, Kallman CH: Early discharge following acute myocardial infarction. Long-term follow-up of randomized patients.Archives of Internal Medicine. 1982,142:875–878.PubMedCrossRefGoogle Scholar
  28. (28).
    Fridlund B, Högstedt B, Lidell E, Larsson PA: Recovery after myocardial infarction: Effects of a caring rehabilitation program.Scandinavian Journal of Caring Sciences. 1991,5:23–32.PubMedGoogle Scholar
  29. (29).
    Campbell NC, Thain J, Deans HG, et al.: Secondary prevention clinics for coronary heart disease: Randomised trial of effect on health.British Medical Journal. 1998,316:1434–1437.PubMedGoogle Scholar
  30. (30).
    Schmitz JM, Spiga R, Rhoades HM, Fuentes F, Grabowski J: Smoking cessation in women with cardiac risk: A comparative study of two theoretically based therapies.Nicotine & Tobacco Research. 1999,1:87–94.CrossRefGoogle Scholar
  31. (31).
    Prochaska JO, DiClemente CC: The transtheoretical approach. In Norcross JC (ed),Handbook of Eclectic Psychotherapy. New York: Brunner/Mazel, 1986, 163–200.Google Scholar
  32. (32).
    Rollnick S, Butler CC, Stott N: Helping smokers make decisions: The enhancement of brief intervention for general medical practice.Patient Education and Counseling. 1997,31:191–203.PubMedCrossRefGoogle Scholar
  33. (33).
    Rosal MC, Ockene JK, Ma Y, et al.: Coronary Artery Smoking Intervention Study (CASIS): 5-year follow-up.Health Psychology. 1998,17:476–478.PubMedCrossRefGoogle Scholar
  34. (34).
    Rigotti NA, McKool KM, Shiffman S: Predictors of smoking cessation after coronary artery bypass graft surgery: Results of a randomized trial with 5-year follow-up.Annals of Internal Medicine. 1994,120:287–293.PubMedGoogle Scholar
  35. (35).
    Hall SM, Delucchi KL, Velicer WF, et al.: Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcome.Nicotine & Tobacco Research. 2001,3:193–202.CrossRefGoogle Scholar
  36. (36).
    Haskell WL, Alderman EL, Fair JM, et al.: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).Circulation. 1994,89:975–990.PubMedGoogle Scholar
  37. (37).
    Velicer WF, Prochaska JO: A comparison of four self-report smoking cessation outcome measures.Addictive Behaviors. 2004,29:51–60.PubMedCrossRefGoogle Scholar
  38. (38).
    Velicer WF, Prochaska JO, Rossi JS, Snow MG: Assessing outcome in smoking cessation studies.Psychological Bulletin. 1992,111:23–41.PubMedCrossRefGoogle Scholar
  39. (39).
    Cochrane Collaboration:Review Manager 4.2.Retrieved April 27, 2004 from http://www.cc-ims.net/RevManGoogle Scholar
  40. (40).
    Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses.British Medical Journal. 2003,327:557–560.PubMedCrossRefGoogle Scholar
  41. (41).
    Deeks J, Group SMW:Statistical methods programmed in meta view.Retrieved April 27, 2004 from http://www.cochrane.org/ docs/statisticalmethods.pdfGoogle Scholar
  42. (42).
    Allen JK: Coronary risk factor modification in woman after coronary artery by pass surgery.Nursing Research. 1996,45:260–265.PubMedCrossRefGoogle Scholar
  43. (43).
    Burt A, Thornley R, Illingworth D, et al.: Stopping smoking after myocardial infarction.Lancet. 1974,1:304–306.PubMedCrossRefGoogle Scholar
  44. (44).
    Carlsson R, Lindberg G, Westin L, Israelsson B: Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction.Heart. 1997,77:256–259.PubMedGoogle Scholar
  45. (45).
    Ockene JK, Kristeller J, Goldberg R, et al.: Smoking cessation and severity of disease: The coronary artery smoking intervention study.Health Psychology. 1992,11:119–126.PubMedCrossRefGoogle Scholar
  46. (46).
    DeBusk RF, Miller N, Superko HR, et al.: Acase-management system for coronary risk factor modification after acute myocardial infarction.Annals of Internal Medicine. 1994,120:721–729.PubMedGoogle Scholar
  47. (47).
    Dornelas EA, Sampson RA, Gray JF, Waters D, Thompson PD: A randomized controlled trial of smoking cessation counseling after myocardial infarction.Preventive Medicine. 2000,30:261–268.PubMedCrossRefGoogle Scholar
  48. (48).
    Feeney GFX, McPherson A, Connor JP, et al.: Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction.Internal Medicine Journal. 2001,31:470–475.PubMedCrossRefGoogle Scholar
  49. (49).
    Hajek P, Taylor TZ, Mills P: Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomised controlled trial.British Medical Journal. 2002,324:1–5.CrossRefGoogle Scholar
  50. (50).
    Heller RF, Knapp JC, Valenti LA, Dobson AJ: Secondary prevention after acute myocardial infarction.American Journal of Cardiology. 1993,72:759–762. 20PubMedCrossRefGoogle Scholar
  51. (51).
    Lisspers J, Sundin O, Hofman-Bang C, et al.: Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: A prospective, randomized, controlled study.Journal of Psychosomatic Research. 1999,46:143–154.PubMedCrossRefGoogle Scholar
  52. (52).
    Mitsibounas DN, Tsouna-Hadjis ED, Sideris DA, Rotas AR: Effects of group psychsocial intervention on coronary risk factors.Psychotherapy and Psychosomatics. 1992,58:97–102.PubMedCrossRefGoogle Scholar
  53. (53).
    Ortigosa Moreno A, Ochoa Gomez FJ, Ramalle Gomara E, et al.: Eficacia de una intervencion para dejar de fumar en pacientes con infarto de miocardio [Efficacy of a smoking cessation intervention for patients with myocardial infarction].Medicina Clinica (Barc). 2000,114:209–210.Google Scholar
  54. (54).
    Quist-Paulsen P, Gallefoss F: Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease.British Medical Journal. 2003,327:1254–1257.PubMedCrossRefGoogle Scholar
  55. (55).
    Reid R, Pipe A, Higginson L, et al.: Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease.Journal of Cardiopulmonary Rehabilitation. 2003,23:176–182.PubMedCrossRefGoogle Scholar
  56. (56).
    Sivarajan ES, Newton KM, Almes MJ, et al.: Limited effects of outpatient teaching and counseling after myocardial infarction: a controlled study.Heart and Lung. 1983,12:65–73.PubMedGoogle Scholar
  57. (57).
    Taylor CB, Houston-Miller N, Killen JD, DeBusk RF: Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention.Annals of Internal Medicine. 1990,113:118–123.PubMedGoogle Scholar
  58. (58).
    van Elderen T, Maes S, Seegers G: Effects of a post-hospitalization group health education programme for patients with coronary heart disease.Psychology and Health. 1994,9:317–330.CrossRefGoogle Scholar
  59. (59).
    van Elderen T, Maes S, van den Broek Y: Effects of a health education programme with telephone follow-up during cardiac rehabilitation.British Journal of Clinical Psychology. 1994,33:367–378.Google Scholar
  60. (60).
    Schulz KF, Grimes DA: Generation of allocation sequences in randomised trials: Chance, not choice.Lancet. 2002,359:515–519.PubMedCrossRefGoogle Scholar
  61. (61).
    Schulz KF, Grimes DA: Allocation concealment in randomised trials: Defending against deciphering.Lancet. 2002,359:614–618.PubMedCrossRefGoogle Scholar
  62. (62).
    Jüni P, Altman G, Egger M: Assessing the quality of controlled clinical trials.British Medical Journal. 2001,323:42–46.PubMedCrossRefGoogle Scholar
  63. (63).
    Woodward M, Tunstall-Pedoe H: Biochemical evidence of persistent heavy smoking after a coronary diagnosis despite self-reported reduction: analysis from the Scottish Heart Health Study.European Heart Journal. 1992,13:160–165.PubMedGoogle Scholar
  64. (64).
    Patrick DL, Cheadle A, Thompson DC, et al.: The validity of self-reported smoking: A review and meta-analysis.American Journal of Public Health. 1994,84:1086–1093.PubMedCrossRefGoogle Scholar
  65. (65).
    Begg C, Cho M, Eastwood S, et al.: Improving the quality of reporting of randomized controlled trials: The CONSORT statement.Journal of the American Medical Association. 1996,276:637–639.PubMedCrossRefGoogle Scholar
  66. (66).
    Silagy C, Lancaster T, Stead L, Mant D, Fowler G:Nicotine replacement therapy for smoking cessation. Retrieved February 6, 2005, from Cochrane Library.Google Scholar
  67. (67).
    Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation: A metaanalysis.Journal of the American Medical Association. 1994,271:1940–1947.PubMedCrossRefGoogle Scholar
  68. (68).
    Fredrickson PA, Hurt RDL, Wingender L, et al.: High dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine levels.Psychopharmacology. 1995,122:215–222.PubMedCrossRefGoogle Scholar
  69. (69).
    Ottervanger JP, Festen JM, de Vries AG, Stricker BH: Acute myocardial infarction while using the nicotine patch.Chest. 1995,107:1765–1766.PubMedCrossRefGoogle Scholar
  70. (70).
    Keeley EC, Pirwitz MJ, Landau C, et al.: Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions.The American Journal of Medicine. 1996,101:357–363.PubMedCrossRefGoogle Scholar
  71. (71).
    Tzivoni D, Keren A, Meyler S, et al.: Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking.Cardiovascular Drugs and Therapy. 1998,12:239–244.PubMedCrossRefGoogle Scholar
  72. (72).
    Tanus-Santos JE, Toledo JCY, Cittadino M, et al.: Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers.American Journal of Hypertension. 2001,14:610–614.PubMedCrossRefGoogle Scholar
  73. (73).
    Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease.Archives of Internal Medicine. 1994,154:989–995.CrossRefGoogle Scholar
  74. (74).
    Joseph AM, Norman SM, Ferry LH, et al.: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease.The New England Journal of Medicine. 1996,335:1792–1798.PubMedCrossRefGoogle Scholar
  75. (75).
    Joseph AM, Fu SS: Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.Progress in Cardiovascular Diseases. 2003,45:429–441.PubMedCrossRefGoogle Scholar
  76. (76).
    Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.Journal of American College of Cardiology. 1997,29:1422–1431.CrossRefGoogle Scholar
  77. (77).
    Spinler SA, Hilleman DE, Cheng JWM, et al.: New recommendations from the 1999- American College of Cardiology/American Heart Association acute myocardial infarction guidelines.The Annals of Pharmacotherapy. 2001,35:589–617.PubMedCrossRefGoogle Scholar
  78. (78).
    McRobbie H, Hajek P: Nicotine replacement therapy in patients with cardiovascular disease: Guidelines for health professionals.Addiction. 2001,96:1547–1551.PubMedCrossRefGoogle Scholar
  79. (79).
    Wulsin LR, Bonita S: Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review.Psychosomatic Medicine. 2003,65:201–210.PubMedCrossRefGoogle Scholar
  80. (80).
    Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis.Psychosomatic Medicine. 2004,66:802–813.PubMedCrossRefGoogle Scholar
  81. (81).
    Hughes J, Stead L, Lancaster T:Antidepressants for smoking cessation. Retrieved February 22, 2005 from the Cochrane Library.Google Scholar
  82. (82).
    Tonstad S, Farsang C, Klaene G, et al.: Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicenter randomised study.European Heart Journal. 2003,24:946–955.PubMedCrossRefGoogle Scholar
  83. (83).
    Riemsma RP, Pattenden J, Bridle C, Sowden A, Mather L: Systematic review of the effectiveness of stage based interventions to promote smoking cessation.British Medical Journal. 2003,326:1175–1182.PubMedCrossRefGoogle Scholar
  84. (84).
    vanSluis EMF, vanPoppel MNM, vanMechelen W: Stage-based lifestyle interventions in primary care. Are they effective?American Journal of Preventive Medicine. 2004,26:330–343.Google Scholar

Copyright information

© The Society of Behavioral Medicine 2006

Authors and Affiliations

  • Jürgen Barth
    • 2
  • Jürgen Bengel
    • 2
  • Julia Critchley
    • 1
  1. 1.School of Population and Health Sciences University of Newcastle upon TyneUSA
  2. 2.Department of Rehabilitation PsychologyUniversity of Freiburg, Institute of PsychologyFreiburgGermany

Personalised recommendations